Chrysos Corp Ltd
ASX:C79
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.49
9.2
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one C79 stock under the Base Case scenario is 2.94 AUD. Compared to the current market price of 7.34 AUD, Chrysos Corp Ltd is Overvalued by 60%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Chrysos Corp Ltd.
| US |
|
Cintas Corp
NASDAQ:CTAS
|
|
| US |
|
Copart Inc
NASDAQ:CPRT
|
|
| AU |
|
Brambles Ltd
ASX:BXB
|
|
| CA |
|
Ritchie Bros Auctioneers Inc
TSX:RBA
|
|
| FR |
|
Spie SA
PAR:SPIE
|
|
| US |
|
Aurora Innovation Inc
NASDAQ:AUR
|
|
| FR |
|
Elis SA
PAR:ELIS
|
|
| IN |
|
Indian Railway Catering and Tourism Corporation Ltd
NSE:IRCTC
|
|
| US |
I
|
IAA Inc
F:3NI
|
|
| DK |
|
Iss A/S
CSE:ISS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Chrysos’s growth heavily depends on the mining industry’s willingness to shift from traditional fire assay methods, and a prolonged slump in exploration budgets could slow PhotonAssay adoption, undermining revenue growth expectations.
Despite its advantages, PhotonAssay units require significant initial capital outlay, which may deter smaller miners and create unpredictable demand cycles tied to gold prices and liquidity in the mining sector.
The company’s reliance on strategic partnerships with large gold producers introduces concentration risk; if any major partner scales back or faces operational challenges, Chrysos’s revenue streams and market reputation could be adversely affected.
PhotonAssay technology offers a faster, safer, and more accurate gold analysis alternative, potentially displacing legacy fire assay methods on a global scale and driving strong recurring revenues from service agreements.
Chrysos’s ability to secure long-term contracts with top-tier gold producers and exploration firms highlights the commercial viability of its technology, supporting stable cash flows and growth optionality.
The patent-protected nature of PhotonAssay, along with ongoing R&D investments, establishes high barriers to entry for competitors, providing Chrysos with durable competitive advantage in the assay market.
Revenue & Expenses Breakdown
Chrysos Corp Ltd
Balance Sheet Decomposition
Chrysos Corp Ltd
| Current Assets | 64.2m |
| Cash & Short-Term Investments | 21.5m |
| Receivables | 27.7m |
| Other Current Assets | 14.9m |
| Non-Current Assets | 200.2m |
| Long-Term Investments | 100k |
| PP&E | 190.5m |
| Intangibles | 6.4m |
| Other Non-Current Assets | 3.1m |
| Current Liabilities | 43.4m |
| Accounts Payable | 19.4m |
| Accrued Liabilities | 14.5m |
| Other Current Liabilities | 9.5m |
| Non-Current Liabilities | 22.6m |
| Long-Term Debt | 19.6m |
| Other Non-Current Liabilities | 3m |
Free Cash Flow Analysis
Chrysos Corp Ltd
| AUD | |
| Free Cash Flow | AUD |
Earnings Waterfall
Chrysos Corp Ltd
|
Revenue
|
67.3m
AUD
|
|
Operating Expenses
|
-65.2m
AUD
|
|
Operating Income
|
2.1m
AUD
|
|
Other Expenses
|
-10.3m
AUD
|
|
Net Income
|
-8.2m
AUD
|
C79 Profitability Score
Profitability Due Diligence
Chrysos Corp Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Score
Chrysos Corp Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
C79 Solvency Score
Solvency Due Diligence
Chrysos Corp Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Chrysos Corp Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
C79 Price Targets Summary
Chrysos Corp Ltd
According to Wall Street analysts, the average 1-year price target for C79 is 8.79 AUD with a low forecast of 6.57 AUD and a high forecast of 10.5 AUD.
Dividends
Current shareholder yield for C79 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one C79 stock under the Base Case scenario is 2.94 AUD.
Compared to the current market price of 7.34 AUD, Chrysos Corp Ltd is Overvalued by 60%.